Jump to content

Drilldown: Medicines

Choose a table:


Medicines > generic : 2-FDCK or 25I-NBOMe or Psilocybin

Use the filters below to narrow your results.

generic: (Click arrow to add another value)
brand:
None (2) · COMP360 (Compass Pathways, investigational synthesized clinical formulation) (1)
classes:
Classic Psychedelic (1) · Dissociative (1) · Phenethylamine (1) · Research material (2) · [[:Category:Classical Psychedelics (Serotonergic)|Serotonergic psychedelic]] (1) · [[:Category:Psychedelics|Psychedelic]] (1) · [[:Category:Tryptamines|Tryptamine]] (1)
mechanism:
Extremely potent 5-HT2A agonist; vasoconstrictor (1) · NMDA antagonist; fluorinated ketamine analogue (1) · Prodrug to [[Psilocin|psilocin]] (4-hydroxy-N,N-dimethyltryptamine), a partial agonist at the [[Receptor:5-HT2A|5-HT2A]] serotonin receptor; the action that defines the classical-psychedelic mechanism (1)
uses:
None (2) · (investigational) '"`UNIQ--vote-000000EF-QINU`"', '"`UNIQ--vote-000000F0-QINU`"', '"`UNIQ--vote-000000F1-QINU`"', '"`UNIQ--vote-000000F2-QINU`"', '"`UNIQ--vote-000000F3-QINU`"' (1)
starting dose:
None (2) · Modern clinical-trial standard: 25 mg synthesized psilocybin, single oral dose with psychological support (1)
preparations:
None (2) · Synthesized psilocybin capsules (COMP360 and other investigational formulations); dried whole [[Psilocybe|Psilocybe]] mushrooms (variable potency, no legal supply chain in most jurisdictions); psilocybin truffles (Psilocybe sclerotia, legal in the Netherlands) (1)
fda max:
None (2) · Not FDA-approved; clinical-trial protocols use up to 30 mg in adult investigational dosing (1)
routes:
None (2) · Oral (1)
onset:
None (2) · 20-45 min subjective onset; psilocin formation from psilocybin requires intestinal and hepatic alkaline phosphatase (1)
duration:
None (2) · 4-6 hours (1)
halflife:
None (2) · Psilocin: ~2-3 h; psilocybin itself is a prodrug, dephosphorylated within minutes of absorption (1)
bioavailability:
None (2) · Oral bioavailability of psilocin from administered psilocybin approximately 50% (1)
pregnancy:
None (2) · Not studied in human pregnancy; no approved clinical use in any population (1)
legal:
None (3)

Showing below up to 3 results in range #1 to #3.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

2


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"